As of May 2026 Neurocrine Biosciences has a market cap of โฌ13.56 Billion. This makes Neurocrine Biosciences the world's 1405th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 17th, 2026 the market cap of Neurocrine Biosciences was reported to be: